| EPB198 | Optimizing ART for CALHIV by shifting PI-based ART to dolutegravir-based ART maintained and achieved viral load suppression | E-poster | ARV management strategies in paediatric and adolescent populations |
| EPB197 | Adverse perinatal outcomes associated with highly active antiretroviral therapy and monotherapy in women living with HIV: a systematic review and meta-analysis | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB196 | Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB195 | Impact of point-of-care HIV viral load and drug resistance testing among pregnant and postpartum women living with HIV in Western Kenya: apre- and post-intervention study | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB194 | A multicentre observational study to determine the safety and effectiveness of dolutegravir (DTG) use during pregnancy: data from DOLOMITE-NEAT ID Network study | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB193 | Associations between HIV/ART exposure during pregnancy and adverse maternal and infant outcomes in the MANGO cohort in western Kenya | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB192 | Impact of mother mentors' model to improve retention in PMTCT services in health facilities supported by Global Funds. a case from Christian Social Services Commission (CSSC)-AMREF, Tanzania | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB191 | Periconceptional dolutegravir use and risk of adverse pregnancy outcomes in Kenya | E-poster | Sex-specific (including cis- and transgender) issues of ART efficacy, adverse reactions and complications |
| EPB190 | Do ART and chemsex drugs get along? Potential drug-drug interactions in a cohort of HIV-positive chemsex users | E-poster | Sex-specific (including cis- and transgender) issues of ART efficacy, adverse reactions and complications |
| EPB189 | Construction and validation of a questionnaire to measure adverse effects of antiretrovirals in the Mexican population | E-poster | Adherence |